Cannapharmarx Stock Performance
| CPMD Stock | USD 0.01 0.00 0.00% |
On a scale of 0 to 100, CannaPharmaRx holds a performance score of 3. The firm shows a Beta (market volatility) of -6.32, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning CannaPharmaRx are expected to decrease by larger amounts. On the other hand, during market turmoil, CannaPharmaRx is expected to outperform it. Please check CannaPharmaRx's total risk alpha, downside variance, day median price, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether CannaPharmaRx's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CannaPharmaRx are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent primary indicators, CannaPharmaRx exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 335 K | |
| Total Cashflows From Investing Activities | 533.1 K |
CannaPharmaRx |
CannaPharmaRx Relative Risk vs. Return Landscape
If you would invest 0.78 in CannaPharmaRx on December 20, 2024 and sell it today you would lose (0.23) from holding CannaPharmaRx or give up 29.49% of portfolio value over 90 days. CannaPharmaRx is currently generating 0.9215% in daily expected returns and assumes 18.2398% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CannaPharmaRx, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CannaPharmaRx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CannaPharmaRx's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CannaPharmaRx, and traders can use it to determine the average amount a CannaPharmaRx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0505
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CPMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 18.24 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.92 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average CannaPharmaRx is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CannaPharmaRx by adding it to a well-diversified portfolio.
CannaPharmaRx Fundamentals Growth
CannaPharmaRx Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CannaPharmaRx, and CannaPharmaRx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CannaPharmaRx Pink Sheet performance.
| Return On Equity | -2.51 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | 20.13 M | |||
| Shares Outstanding | 257.57 M | |||
| Price To Book | 11.05 X | |||
| EBITDA | (6.07 M) | |||
| Cash And Equivalents | 5.18 K | |||
| Total Debt | 14.96 M | |||
| Debt To Equity | 7.05 % | |||
| Book Value Per Share | (0.07) X | |||
| Cash Flow From Operations | (2.41 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 114.33 K | |||
| Retained Earnings | (28.64 M) | |||
| Current Asset | 233 K | |||
| Current Liabilities | 518 K | |||
About CannaPharmaRx Performance
By analyzing CannaPharmaRx's fundamental ratios, stakeholders can gain valuable insights into CannaPharmaRx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CannaPharmaRx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CannaPharmaRx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. The company was incorporated in 1998 and is based in Calgary, Canada. Cannapharmarx operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about CannaPharmaRx performance evaluation
Checking the ongoing alerts about CannaPharmaRx for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CannaPharmaRx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CannaPharmaRx is way too risky over 90 days horizon | |
| CannaPharmaRx has some characteristics of a very speculative penny stock | |
| CannaPharmaRx appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (8.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CannaPharmaRx currently holds about 5.18 K in cash with (2.41 M) of positive cash flow from operations. |
- Analyzing CannaPharmaRx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CannaPharmaRx's stock is overvalued or undervalued compared to its peers.
- Examining CannaPharmaRx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CannaPharmaRx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CannaPharmaRx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CannaPharmaRx's pink sheet. These opinions can provide insight into CannaPharmaRx's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CannaPharmaRx Pink Sheet analysis
When running CannaPharmaRx's price analysis, check to measure CannaPharmaRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannaPharmaRx is operating at the current time. Most of CannaPharmaRx's value examination focuses on studying past and present price action to predict the probability of CannaPharmaRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannaPharmaRx's price. Additionally, you may evaluate how the addition of CannaPharmaRx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |